Microsoft PowerPoint - L00 Introduction

398 / 1068

The Royal Marsden Overall Survival by TRG (1-2 v 3 v 4-5)
after Chemo-Radiotherapy
in EXPERT-C trial (both arms)
mrTRG1-2
89.8%
65.9%
67.5%
mrTRG1-2, 39.8%
mrTRG3 , 29%
mrTRG4-5, 31%